SHR-A1904 Injection

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Beijing GoBroad Hospital

Conditions

Advanced Gastric CancerAdvanced Neuroendocrine CarcinomaGastroesophageal Junction AdenocarcinomaMetastatic Gastric Cancer

Phase 2

Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

RecruitingNCT07102901

Jiangsu HengRui Medicine Co., Ltd.Advanced Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Cancer

Start: 2025-09-05End: 2027-12-31Target: 351Updated: 2025-09-10

A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma

Not yet recruitingNCT07520357

Beijing GoBroad HospitalAdvanced Neuroendocrine Carcinoma

Start: 2026-04-30End: 2029-02-28Target: 23Updated: 2026-04-09